Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/21 16:43 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | P.d | 7,125 | 19.00 | 0 | 375 | 20 | 2,223 | I | ||||||||||||||
3/17/21 19:47 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Point72 Biotech Private Investments, LLC | CT | H | Former 1 | P.d | 15,200 | 19.00 | 0 | 800 | 43 | 2,648 | I | ||||||||||||||
3/16/21 21:49 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Stenhouse Mark | CA | O | COO | P | 266 | 19.00 | 0 | 14 | New | 14 | D | ||||||||||||||
3/16/21 21:48 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Papa Joseph C | CA | D | P | 285 | 19.00 | 0 | 15 | New | 15 | D | |||||||||||||||
3/16/21 21:47 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Adams Helen C. | CA | D | P | 10 | 19.00 | 0 | 1 | New | 1 | D | |||||||||||||||
3/16/21 20:30 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Perceptive Advisors LLC | NY | T | P.d | 16,150 | 19.00 | 0 | 850 | 34 | 3,314 | I | |||||||||||||||
3/16/21 19:57 | 3/16/21 | RXDX | Health | Drug | Pharmaceutical Preparations | Rtw Investments, LP | NY | T | P.d | 15,200 | 19.00 | 0 | 800 | 32 | 3,264 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |